garenoxacin has been researched along with metoprolol in 1 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (metoprolol) | Trials (metoprolol) | Recent Studies (post-2010) (metoprolol) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 5,821 | 1,743 | 1,304 |
| Protein | Taxonomy | garenoxacin (IC50) | metoprolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 2.573 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.176 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 4.87 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 4.87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinushi, M; Nakamura, Y; Ochiai, S; Sato, A; Tagawa, M | 1 |
1 other study(ies) available for garenoxacin and metoprolol
| Article | Year |
|---|---|
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.
Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Bacterial Agents; Electrocardiography; Emergency Service, Hospital; Epinephrine; ERG1 Potassium Channel; Exercise Test; Female; Fluoroquinolones; Genetic Predisposition to Disease; Heart Rate; Humans; Long QT Syndrome; Metoprolol; Mutation; Phenotype; Predictive Value of Tests; Recurrence; Risk Factors; Syncope | 2016 |